Vanguard Group Inc Senti Biosciences, Inc. Transaction History

Vanguard Group Inc

  • $5.46 Trillion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$0.28 - $0.68 $43,092 - $104,652
153,900 Added 27.82%
707,052 $466,000
Q2 2023

Aug 14, 2023
BUY
$0.6 - $1.14 $22,632 - $43,001
37,721 Added 7.32%
553,152 $348,000
Q4 2022

Feb 10, 2023
BUY
$1.25 - $65.2 $644,288 - $33.6 Million
515,431 New
515,431 $726,000

Others Institutions Holding SNTI

# of Institutions
3
Shares Held
342K
Call Options Held
0
Put Options Held
0
View Full List

About Senti Biosciences, Inc.

SNTI Quotes by TradingView
  • Ticker SNTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,757,100
  • Market Cap $172M
  • Description
  • Senti Biosciences, Inc. operates as a gene circuit company. The company develops cell and gene therapies engineered with gene circuits that are designed to reprogram cells with biological logic to sense inputs, compute decisions, and respond to respective cellular environments. Its synthetic biology platform utilizes off-the-shelf chimeric antig...
More about SNTI
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email